DCIS kunye ne-LCIS: I-Cancer okanye Akunjalo?
Kuthetha ntoni ukuxelelwa ukuba unomdlavuza wesibeleko sebele? Ukudideka malunga nokuba zeziphi iindlela ezithatha isisombululo kunokukhokelela ekungaqondeni imeko, inkqubo yokonyango, kunye neziphumo.
I-DCIS okanye iSigaba 0 I-Cancer yesisu idla ngokungaqondakaliyo
Abantu abaninzi abaye bafumanisa ukuba bane-ductal carcinoma in situ (i-DCIS) okanye isigaba se-0 somhlaza wesibeletho bafumanisa uxhalaba xa bethetha nabanye.
Abanye abantu bathetha ngokuthi "akukona umhlaza wecala" okanye "awusengozini nonke" kwaye le miyalezo inokuba buhlungu kakhulu. Emva koko, abaninzi bala bantu baye baphathwa ngokuhlinzwa kunye nemisebe kwaye bajonga iminyaka emihlanu okanye ngaphezulu kokusebenzisa unyango lwe-hormone . Amagqabaza anjalo awanakulungelelanisa, kwaye ushiya abafazi beva ukuba ukuxilongwa kwabo kuye kwaxatyiswa kwaye iimvakalelo zabo zixothwe.
Naluphi na ukuxilongwa komhlaza okanye i-precancer (nokuba yeyiphi na into) iyatshisa. Ucwaningo luye lwafumanisa ukuba iimvakalelo zabantu abazenzayo ngexesha lokuxilongwa ziyafana nokuba umntu ufumanisa ukuba une-tumor yokuqala ephilisa kakhulu okanye i-tumor esesigxina esingenawo ithuba lokunyanga.
Oku kudideka ngenxa yokuxilongwa kwe-cancer yebele. Makhe sijonge izizathu zokudideka kwaye sifumane ukuba zeziphi izibakala ze-cancer zebele ze- DCIS kunye nomzala wakhe uLCIS (lobular carcinoma in situ).
I-Cancer In Situ
Ukuxilongwa kwe-carcinoma in situ kunentsingiselo ethile. In situ kuthetha ukuba iiseli zomhlaza zonke "zikhona" kwaye zingenasiphelo. I-carcinoma in situ , ingaba ifumaneka kwicala lobisi lwakho lobisi okanye ngaphakathi kwelobes apho ubisi lwebele luveliswa khona, luyi-clump yeeseli. Ama-oncologists abiza lolu hlobo lokuxilongwa kwendawo yolu hlobo ngenxa yokuba aluzange luphuluke kwindawo (alufaki ngaphezu kwento ebizwa ngokuba yimbumba), kwaye ayizange ifikelele kwezinye iifom.
Iiseli ze-carcinoma zibukeka zifana nomhlaza wesifo somhlaza wesiqhaqhozo, umlinganiselo ophela kukuba iiseli zisasazeka kangakanani.
Izifo zomhlaza zesibindi ezixhamlayo zinikezelwa isigaba senqanaba ukusuka kwelinye ukuya kwezine kwaye kubalulekile ukukhumbula ukuba izigaba eziphantsi zilula ukunyanga, okubangelwa kwizinga eliphezulu lokusinda.
Isigaba seZero Cancer Breast
Ikomidi eliManyeneyo laseMelika kwiCarcer (AJCC) lipapasha imigangatho apho i-cancer iyenziwa khona. Umdlavuza wesifuba uqhutywe yinkqubo ye-TNM, kunye namanani abelwe amanqaku kwi-Tumor, Nodes, kunye neMetastasis. I-Tis N0 M0 ichaza i-DCIS kunye ne-LCIS kunye nesifo sikaPaget se-ingono , ukuba akukho sithotho sitholakale.
- I-Tis ithetha ukuba akukho nto ifunyanwe, kodwa iiseli ezingaqhelekanga zikhoyo.
- I-N0 ithetha ukuba akukho lymph nodes ezibandakanyekayo.
- I-M0 iqinisekisa ukuba akukho mastasis eyenziwe.
Yilokho i-oncologist ithetha xa ixelela ukuba unomdlavuza wesifo sebele.
I-Precancer okanye i-Noninvasive Cancer?
Abanye oogqirha basebenzisa imimiselo engathandabuzekiyo kunye nomdlavuza ongenakuvakalayo kanti abanye babhekisela kwisifo somhlaza wesibeleko se-0 "njengomhlaza." Ngayiphi indlela, bathetha malunga nenkqubo efanayo kuphela ngamagama ahlukeneyo.
Kodwa xa uva igama elithi "ngqangi," unokukhathazeka ukuba unesimo esiza kuqhubela phambili umhlaza, kwaye kufuneka siphathwe njengolu hlobo.
Emva koko, ukuba uxelelwa ukuba ukuxilongwa kwakho "ngumhlaza ongenasvasive," ungashenxisa xa uva ilizwi elithi "C"! Masijamelane nayo: Asiyithandi naliphi ixesha, ngokukodwa xa libhekisela kwiibele zethu.
Ngaba isifo seZero okanye ungazi?
Bobabini i-ductal ne-lobular carcinoma in situ zixhalaba kuba zinako ukuhlaselwa ngaphaya kweendawo zabo ezixhomekeke kuzo. Izazinzulu azikwazi ukuchaza ngokuthe ngqo ukuba zeziphi abantu abasengozini yokuhlaselwa ngumhlaza wesibeleko esingenayo ukuba i-DCIS okanye i-LCIS ishiywe ingaphatywa. Zombili i-carcinomas zinokubonakala kwimizimba yesifo somhlaza kwaye zombini ziyakwazi ukukhula zize zisasaze ngaphaya kweentlobo zazo zangaphambili, okanye zingenako.
Ekubeni kunakho ukuhlakulela umdlavuza ongenayo, abaninzi abantu kunye noogqirha babo bakhetha ukhathaza isigaba se-0 somhlaza wesifuba njengoko babeza kuba ngumhlaza wesiqhelo (isigaba sam ukuya kwisigaba IV).
Ezinye izinto ezininzi zichaphazela isicwangciso sakho soonyango. Ezinye zezi ziquka:
- IHormone
- Umngcipheko we-Genetic
- Isimo seMenaopausal
- Okukhethwa ngumntu
Izinyango Zonyango
Izinketho zokwelapha ziyahlukahluka ngokwemiqathango engentla kunye nezinye.
Abanye oncologists banokukuxelela ukuba "ulindile ulinde" ukubona ukuba i-carcinoma iza kuzinyulula okanye iya kuqhuba. Abanye oogqirha baya kuqhubeka becebisa unyango lomhlaza. Abanye abantu "bafuna nje" ukuba kukho ithuba lokuba isigaba se-0 singaba ngumhlaza ongenawo umonakalo, ngelixa abanye abantu bekhululekile ngendlela yokulinda kunye nokulandelelanayo ngokulandelelana.
Izinyango zokwenza unyango zingabandakanya i-lumpectomy elandelwa yimitha, okanye i- mastectomy ukuba kukho inkxalabo yokuba kunokukho ezinye iindawo ze-DCIS okanye i-LCIS kwibele okanye ukuba ibhinqa inenkqubela kwintsapho yomhlaza wesibele. I-hormone therapy ingayilandela ubuncinane ubuncinane iminyaka emi-5, kunye ne-tamoxifen isoloko isetyenziselwa abafazi be-premenopausal kunye ne-aromatase inhibitors kulabo abasemva kwe-postmenopausal.
Ngayiphi na indlela, uya kuthatha izigqibo ezingenakuthatheka kunye neentlobo zeemvakalelo. Abantu abaza kukuxhasa kufuneka bahlonele ukuba kungakhathaliseki ukuba uxilongwa njani.
Ngoko, ingaba isiteji sinomdlavuza webele, okanye akunjalo? Oogqirha abavumiyo ngoku, kodwa leyo yimiba yesigama. Musa ukuxhomekeka kumazwi, kodwa qwa lasela ukufumana uluvo lwesibini, ukuqinisekisa ukuba ufumana unyango olungcono kakhulu nolona lusebenzayo kwimpilo yakho.
> Imithombo:
> Rosso, K., Weiss, A., no-A. Thompson. Ngaba zikhona iindlela ezizodwa zoLawulo lweNgingqi ye-Ductal Carcinoma kwi-Situ. Iiklinikhi ze-Oncology zase-North America . 2018. 27 (1): 9-80.
> Toss, M., Miligy, I., Thompson, A. et al. Iimvavanyo zangoku ukunciphisa ukungenelela kokutyikitya kwi-Ductal Carcinoma kwiimeko zoBustile: UkuHlola okuBalulekileyo. Isisu . 2017. 35: 151-156.